Natural products for drug discovery in the 21st century: innovations for novel drug discovery
NE Thomford, DA Senthebane, A Rowe… - International journal of …, 2018 - mdpi.com
The therapeutic properties of plants have been recognised since time immemorial. Many
pathological conditions have been treated using plant-derived medicines. These medicines …
pathological conditions have been treated using plant-derived medicines. These medicines …
Counting on natural products for drug design
Natural products and their molecular frameworks have a long tradition as valuable starting
points for medicinal chemistry and drug discovery. Recently, there has been a revitalization …
points for medicinal chemistry and drug discovery. Recently, there has been a revitalization …
Inhibitors of protein–protein interactions (PPIs): an analysis of scaffold choices and buried surface area
X Ran, JE Gestwicki - Current opinion in chemical biology, 2018 - Elsevier
Protein–protein interactions (PPI) were once considered 'undruggable', but clinical
successes, driven by advanced methods in drug discovery, have challenged that notion …
successes, driven by advanced methods in drug discovery, have challenged that notion …
[HTML][HTML] The role of natural products as sources of therapeutic agents for innovative drug discovery
K Dzobo - Comprehensive pharmacology, 2022 - ncbi.nlm.nih.gov
Emerging threats to human health require a concerted effort in search of both preventive and
treatment strategies, placing natural products at the center of efforts to obtain new therapies …
treatment strategies, placing natural products at the center of efforts to obtain new therapies …
[HTML][HTML] Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles
DT Hoang, KA Iczkowski, D Kilari, W See… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …
cause of cancer-related death for American men due to a subset of patients progressing to …
Direct targeting options for STAT3 and STAT5 in cancer
Signal transducer and activator of transcription (STAT) 3 and STAT5 are important
transcription factors that are able to mediate or even drive cancer progression through …
transcription factors that are able to mediate or even drive cancer progression through …
Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia
A Kaneshige, L Bai, M Wang… - Journal of medicinal …, 2023 - ACS Publications
STAT5 is an attractive therapeutic target for human cancers. We report herein the discovery
of a potent and selective STAT5 degrader with strong antitumor activity in vivo. We first …
of a potent and selective STAT5 degrader with strong antitumor activity in vivo. We first …
The pharmacophore concept and its applications in computer-aided drug design
Pharmacophore-based techniques currently are an integral part of many computer-aided
drug design workflows and have been successfully and extensively applied for tasks such …
drug design workflows and have been successfully and extensively applied for tasks such …
Pharmacological inhibition of oncogenic STAT3 and STAT5 signaling in hematopoietic cancers
M Brachet-Botineau, M Polomski, HA Neubauer… - Cancers, 2020 - mdpi.com
Signal Transducer and Activator of Transcription (STAT) 3 and 5 are important effectors of
cellular transformation, and aberrant STAT3 and STAT5 signaling have been demonstrated …
cellular transformation, and aberrant STAT3 and STAT5 signaling have been demonstrated …
STAT5A and STAT5B—twins with different personalities in hematopoiesis and leukemia
The transcription factors STAT5A and STAT5B have essential roles in survival and
proliferation of hematopoietic cells—which have been considered largely redundant …
proliferation of hematopoietic cells—which have been considered largely redundant …